Erratum: Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism British Journal of Cancer (2009) 100 (1926-1936) DOI: 10.1038/sj.bjc.6605072;Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism

British Journal of Cancer

Volumn 100, Issue 12, 2009, Pages 1926-1936

  Beesley, A H ^a   Firth, M J ^a   Ford, J ^a   Weller, R E ^a   Freitas, J R ^a   Perera, K U ^a   Kees, U R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Drug resistance; lymphoid tumours; glucocorticoids; gene expression

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 PHENYLBUTYRIC ACID; BENSERAZIDE; BLEBBISTATIN; CARBAMAZEPINE; CHOLESTEROL; COBALT CHLORIDE; DEFEROXAMINE; DEXAMETHASONE; FLUDROCORTISONE; GELDANAMYCIN; GLUCOCORTICOID; GLUTAMIC ACID; INDOMETACIN; MAMMALIAN TARGET OF RAPAMYCIN; METHYLPREDNISOLONE; MIXED LINEAGE LEUKEMIA PROTEIN; MYC PROTEIN; N (4 AMINOBUTYL) 5 CHLORO 2 NAPSYLAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; QUERCETIN; RAPAMYCIN; RESVERATROL; TAMOXIFEN; TRICHOSTATIN A; WORTMANNIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; GENE EXPRESSION PROFILING; GLYCOLYSIS; HUMAN; HUMAN CELL; IC 50; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 67349261310     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605632     Document Type: Erratum

References (52)

1. Ausserlechner MJ, Obexer P, Wiegers GJ, Hartmann BL, Geley S, Kofler R (2001) The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels. J Biol Chem 276(24): 10984-10989
2. Beesley AH, Cummings AJ, Freitas JR, Hoffmann K, Firth MJ, Ford J, de Klerk NH, Kees UR (2005) The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br J Haematol 131(4): 447-456
3. Beesley AH, Palmer ML, Ford J, Weller RE, Cummings AJ, Freitas JR, Firth MJ, Perera KU, de Klerk N, Kees UR (2006) Authenticity and drug resistance in a panel of acute lymphoblastic cell lines. Br J Cancer 95(11): 1537-1544
4. Beesley AH, Palmer ML, Ford J, Weller RE, Cummings AJ, Freitas JR, Firth MJ, Perera KU, de Klerk NH, Kees UR (2007) In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblas-tic leukaemia. Br J Haematol 137(2): 109-116
5. Beesley AH, Weller RE, Senanayake S, Welch M, Kees UR (2008) Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines. Leuk Res 33(2): 321-325
6. Bhojwani D, Kang H, Moskowitz NP, Min DJ, Lee H, Potter JW, Davidson G, Willman CL, Borowitz MJ, Belitskaya-Levy I, Hunger SP, Raetz EA, Carroll WL (2006) Biological pathways associated with relapse in childhood acute lymphoblastic leukemia: a children's oncology group study. Blood 108(2): 711-717
7. Boag JM, Beesley AH, Firth MJ, Freitas JR, Ford J, Hoffmann K, Cummings AJ, de Klerk NH, Kees UR (2006) Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia. Leukemia 20(10): 1731-1737
8. Bornhauser BC, Bonapace L, Lindholm D, Martinez R, Cario G, Schrappe M, Niggli FK, Schafer BW, Bourquin JP (2007) Low dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway. Blood 110(6): 2084-2091
9. Cutts JL, Melnykovych G (1987) The role of cholesterol in the glucocorticoid-mediated inhibition of cell cycle progression in human acute lymphoblastic leukemia cells. Exp Cell Res 168(1): 95-104
10. Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S, Gadner H, Riehm H, Schrappe M (1999) Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 94(4): 1209-1217
11. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L, Adams JM, Strasser A, Villunger A (2005) BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106(13): 4131-4138
12. Flotho C, Coustan-Smith E, Pei D, Cheng C, Song G, Pui CH, Downing JR, Campana D (2007) A set of genes that regulate cell proliferation predict treatment outcome in childhood acute lymphoblastic leukemia. Blood 110(4): 1271-1277
13. Gaynon PS (2005) Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 131(5): 579-587
14. Gilardini Montani MS, Tuosto L, Giliberti R, Stefanini L, Cundari E, Piccolella E (1999) Dexamethasone induces apoptosis in human T cell clones expressing low levels of Bcl-2. Cell Death Differ 6(1): 79-86
15. Gottardo NG, Hoffmann K, Beesley AH, Freitas JR, Firth MJ, Perera KU, de Klerk NH, Baker DL, Kees UR (2007) Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol 137(4): 319-328
16. Harmon JM, Thompson EB (1982) Glutamine synthetase induction by glucocorticoids in the glucocorticoid-sensitive human leukemic cell line CEM-C7. J Cell Physiol 110(2): 155-160
17. Hoffmann K, Firth MJ, Beesley AH, Freitas JR, Ford J, Senanayake S, de Klerk N, Baker DL, Kees UR (2008) Prediction of relapse in paediatric
18. pre-B acute lymphoblastic leukaemia using a three-gene risk index. Br J Haematol 140(6): 656-664
19. Hoffmann K, Firth MJ, Freitas JR, de Klerk NH, Kees UR (2005) Gene expression levels in small specimens from patients detected using oligonucleotide arrays. Mol Biotechnol 29: 31-38
20. Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE (2004) Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. New Engl J Med 351(6): 533-542
21. Holleman A, den Boer ML, Menezes RX, Cheok MH, Cheng C, Kazemier KM, Janka-Schaub GE, Gobel U, Graubner UB, Evans WE, Pieters R (2005) The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 107(2): 769-776
22. Hulleman E, Kazemier KM, Holleman A, Vanderweele DJ, Rudin CM, Broekhuis MJ, Evans WE, Pieters R, Den Boer ML (2009) Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood 113(9): 2014-2021
23. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31(4): e15
24. Irving JA, Minto L, Bailey S, Hall AG (2005) Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course. Cancer Res 65(21): 9712-9718
25. Kaspers GJ, Wijnands JJ, Hartmann R, Huismans L, Loonen AH, Stackelberg A, Henze G, Pieters R, Hahlen K, Van Wering ER, Veerman AJ (2005) Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer 41(9): 1300-1303
26. Kees UR, Ford J, Price PJ, Meyer BF, Herrmann RP (1987) PER-117: a new human ALL cell line with an immature thymic phenotype. Leuk Res 11(5): 489-498
27. Kees UR, Ford J, Watson M, Murch A, Ringner M, Walker RL, Meltzer P (2003) Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease. Mol Cancer Ther 2(7): 671-677
28. Kirschner-Schwabe R, Lottaz C, Todling J, Rhein P, Karawajew L, Eckert C, von Stackelberg A, Ungethum U, Kostka D, Kulozik AE, Ludwig WD, Henze G, Spang R, Hagemeier C, Seeger K (2006) Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia. Clin Cancer Res 12(15): 4553-4561
29. Klumper E, Pieters R, Veerman AJ, Huismans DR, Loonen AH, Hahlen K, Kaspers GJ, van Wering ER, Hartmann R, Henze G (1995) In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood 86(10): 3861-3868
30. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795): 1929-1935
31. Lopes RP, Menna-Barreto M, Bauer ME (2007) Spontaneous cell proliferation is associated with poor sensitivity to glucocorticoids in patients infected with HTLV. Cell Prolif 40(1): 64-74
32. Madden EA, Bishop EJ, Fiskin AM, Melnykovych G (1986) Possible role of cholesterol in the susceptibility of a human acute lymphoblastic leukemia cell line to dexamethasone. Cancer Res 46(2): 617-622
33. Mertens-Talcott SU, Percival SS (2005) Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218(2): 141-151
34. Miccheli A, Tomassini A, Puccetti C, Valerio M, Peluso G, Tuccillo F, Calvani M, Manetti C, Conti F (2006) Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells. Biochimie 88(5): 437-448
35. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J 274(6): 1393-1418
36. Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, van Wering ER, Veerman AJ (1998) Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia - implications for treatment of infants. Leukemia 12(9): 1344-1348
37. Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB (2003) Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 23(20): 7315-7328
38. Reinert RB, Oberle LM, Wek SA, Bunpo P, Wang XP, Mileva I, Goodwin LO, Aldrich CJ, Durden DL, McNurlan MA, Wek RC, Anthony TG (2006) Role of glutamine depletion in directing tissue-specific nutrient stress responses to L-asparaginase. J Biol Chem 281(42): 31222-31233
39. Richards NG, Kilberg MS (2006) Asparagine synthetase chemotherapy. Annu Rev Biochem 75: 629-654
40. Roman-Gomez J, Cordeu L, Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, Calasanz MJ, Heiniger A, Torres A, Prosper F (2007) Epigenetic regulation of WNT signaling pathway in acute lymphoblastic leukemia. Blood 109(8): 3462-3469
41. Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achmuller C, Presul E, Skvortsov S, Crazzolara R, Fiegl M, Raivio T, Janne OA, Geley S, Meister B, Kofler R (2006) Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 107(5): 2061-2069
42. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43): 15545-15550
43. Tissing WJ, Den Boer ML, Meijerink JP, Menezes RX, Swagemakers S, van der Spek PJ, Sallan SE, Armstrong SA, Pieters R (2007) Genome-wide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. Blood 109(9): 3929-3935
44. Tissing WJ, Meijerink JP, den Boer ML, Brinkhof B, van Rossum EF, van Wering ER, Koper JW, Sonneveld P, Pieters R (2005) Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia. Clin Cancer Res 11(16): 6050-6056
45. Tomiyama A, Serizawa S, Tachibana K, Sakurada K, Samejima H, Kuchino Y, Kitanaka C (2006) Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak. J Natl Cancer Inst 98(20): 1462-1473
46. Tonko M, Ausserlechner MJ, Bernhard D, Helmberg A, Kofler R (2001) Gene expression profiles of proliferating vs G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J 15(3): 693-699
47. Warburg O (1956) On the origin of cancer cells. Science 123(3191): 309-314
48. Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, Stam RW, Opferman JT, Sallan SE, den Boer ML, Pieters R, Golub TR, Armstrong SA (2006) Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 10(4): 331-342
49. Winter SS, Jiang Z, Khawaja H, Griffin T, Devidas M, Asselin BL, Larson RS (2007) Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 110(5): 1429-1438
50. Zhang C, Wenger T, Mattern J, Ilea S, Frey C, Gutwein P, Altevogt P, Bodenmuller W, Gassler N, Schnabel PA, Dienemann H, Marme A, Hohenfellner M, Haferkamp A, Pfitzenmaier J, Grone HJ, Kolb A, Buchler P, Buchler M, Friess H, Rittgen W, Edler L, Debatin KM, Krammer PH, Rutz HP, Herr I (2007) Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors. Cancer Biol Ther 6(2): 278-287
51. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18(11): 1272-1282
52. Zunino SJ, Storms DH (2006) Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. Cancer Lett 240(1): 123-134